TROX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tronox Holdings PLC Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire November 02, 2025 NEW YORK, Nov. 02, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action […]

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of F5, Inc. ("F5, Inc.") (NASDAQ:FFIV) concerning possible violations of federal securities laws. F5 disclosed on October 15, 2025, that the company learned on August 9, 2025 "that a highly sophisticated nation-state threat

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alector, Inc. ("Alector, Inc.") (NASDAQ:ALEC) concerning possible violations of federal securities laws. On October 22, 2025, Alector announced results from its Phase 2 INFRONT-3 clinical trial evaluating latozinemab (AL001) in patients with

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=175101&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=175106&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Lantheus Holdings, Inc. (NASDAQ:LNTH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lantheus-holdings-inc-lawsuit-submission-form-2?prid=175109&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Akebia Therapeutics, Inc. ("Akebia Therapeutics, Inc.") (NASDAQ:AKBA) concerning possible violations of federal securities laws. On October 29, 2025, Akebia announced that it will not pursue the VALOR trial for Vafseo label expansion

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Fly-E Group, Inc. (NASDAQ:FLYE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fly-e-group-inc-lawsuit-submission-form?prid=175111&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=175110&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / November 2, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,